Ajooni Biotech Ltd (NSE: AJOONI) is a Mohali, Punjab-based company in the Animal Feed industry. With a market capitalisation of ₹49 Cr, it ranks #3,808 by market cap among the 6,197 Indian listed companies on FinBizNet, and #19 of 22 in Animal Feed. At ₹3.17 (as of 16 Nov 2026), the share price is 42.4% below its 52-week high of ₹5.50 and 18.3% above its 52-week low of ₹2.68. The share price is down 36.6% over one year and down 17.0% over three months.
| Current Price | ₹3.17 |
|---|---|
| Market Cap | ₹49 Cr |
| NSE Symbol | AJOONI |
| Sector | Consumer Staples > Food, Beverage and Tobacco > Food Products |
| Sub-Industry | Packaged Foods and Meats > Animal Feed |
| P/E Ratio | 11.5 |
| Return on Equity | 4.82% |
| Return on Assets | 3.12% |
| 52-Week Range | ₹2.68 – ₹5.50 |
| 1-Year Price Change | -36.6% |
| 3-Month Price Change | -17.0% |
| Beta (1Y) | 0.03 |
| Headquarters | Mohali, Punjab |
| Website | www.ajoonibiotech.com |
| Revenue | ₹65 Cr |
|---|---|
| Net Profit | ₹1 Cr |
| Net Margin | 0.8% |
| EPS (Basic) | ₹0.02 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Ajooni Biotech Ltd reported revenue of ₹65 Cr in Q2 FY27, up 106.0% from ₹32 Cr in Q2 FY26 and up 3.0% from ₹63 Cr in Q1 FY27. It posted a net profit of ₹1 Cr for the quarter, against a net profit of ₹1 Cr in Q2 FY26 (down 45.2%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹29 Cr (Q4 FY25) to ₹65 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹65 Cr | ₹1 Cr | 0.8% |
| Q1 FY27 | ₹63 Cr | ₹0 Cr | 0.7% |
| Q4 FY26 | ₹61 Cr | ₹1 Cr | 1.6% |
| Q3 FY26 | ₹59 Cr | ₹2 Cr | 2.8% |
| Q2 FY26 | ₹32 Cr | ₹1 Cr | 2.9% |
| Q1 FY26 | ₹31 Cr | ₹1 Cr | 2.5% |
| Q4 FY25 | ₹29 Cr | ₹2 Cr | 5.3% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 30.53% of Ajooni Biotech Ltd's shares as of Sept 2026, against 26.89% in Dec 2025 (+3.64 percentage points). Delivery averaged 66.8% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Ajooni Biotech Limited manufactures and sells cattle feed in India. Its portfolio includes cattle feed chips, camel and pig feed, cotton oil cakes, mustard oil cakes, and feed supplements. The company was incorporated in 2010 and is based in Mohali, India.
1. Vitamins & Nutrition Products-This segment manufactures and sells cattle feeds and feed supplements.
1. Vitamins & Nutrition Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Hatsun Agro Product Ltd | ₹23,625 Cr | 66.4 | 19.42% | ₹2,898 Cr | -2.8% |
| Milky Mist Dairy Food | ₹23,295 Cr | 151.3 | — | ₹1,089 Cr | — |
| Manorama Industries Ltd | ₹13,254 Cr | 55.8 | 39.40% | ₹459 Cr | +51.3% |
| Gokul Agro Resources | ₹6,730 Cr | 18.2 | 30.05% | ₹7,481 Cr | +29.6% |
| Dodla Dairy Ltd | ₹5,816 Cr | 21.7 | 17.34% | ₹1,196 Cr | -20.3% |
| Heritage Foods Limited | ₹3,482 Cr | 23.8 | 14.44% | ₹1,320 Cr | -19.0% |
| Venky'S (India) Ltd. | ₹2,272 Cr | 16.4 | 8.20% | ₹1,066 Cr | +2.2% |
| Avt Natural Products Ltd. | ₹1,514 Cr | 23.4 | 12.16% | ₹217 Cr | +34.5% |
| Ajooni Biotech Ltd | ₹49 Cr | 11.5 | 4.82% | ₹65 Cr | -36.6% |
Listed by market capitalisation. Ratios are shown for context only.
Ajooni Biotech Ltd is trading at ₹3.17, with a market capitalisation of ₹49 Cr.
Ajooni Biotech Ltd operates in the Consumer Staples > Food, Beverage and Tobacco > Food Products space (Packaged Foods and Meats > Animal Feed).
Ajooni Biotech Ltd has a P/E of 11.5 and a return on equity of 4.82%.
Ajooni Biotech Ltd is listed on the NSE under the symbol AJOONI.
Ajooni Biotech Ltd's share price is down 36.6% over one year and down 17.0% over three months. Its 52-week range is ₹2.68 to ₹5.50.
In Q2 FY27, Ajooni Biotech Ltd reported revenue of ₹65 Cr and net profit of ₹1 Cr, with basic EPS of ₹0.02 (standalone, parsed from the company's exchange filing).
Ajooni Biotech Ltd reported revenue of ₹65 Cr in Q2 FY27, up 106.0% from ₹32 Cr in Q2 FY26 and up 3.0% from ₹63 Cr in Q1 FY27.
Promoters held 30.53% of Ajooni Biotech Ltd's shares as of Sept 2026, against 26.89% in Dec 2025 (+3.64 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.